APPLY NOW Apply NowVirtual Tour VIRTUAL TOUR
Assistant Professor Dr. Fatokun Omotayo Oladuntoye

Assistant Professor Dr Omotayo Oladuntoye Fatokun

Head of Department, Clinical Pharmacy | Department of Clinical Pharmacy

Academic Qualifications

PhD (Pharmaceutical Policy),
M. Pharm. (Clinical Pharmacy and Biopharmacy)
Bachelor of Pharmacy (Hons)

Areas of Interest
Pharmaceutical Health Services and Policy
Pharmacoepidemiology and Drug Safety
Pharmacoeconomics and Outcomes Research
Professional Bodies Membership

  1. Registered Pharmacist, Pharmacists Council of Nigeria
  2. Member, International Society of Pharmacoepidemiology (ISPE)
  3. Member, International Society of Pharmacoeconomics and Outcomes Research (ISPOR)

Research

Research project

Grants

Collaboration

Status

Integrative Elucidation of Socio-Ecological Drivers of Antimicrobial Resistance Emergence and Transmission at the Human-Animal-Environment Interface

Fundamental Research Grant Scheme (FRGS)

FRGS/1/2021/SKK04/UCSI/02/1

  1. Department of Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, UCSI University
  2. Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM), Malaysia
  3. Department Occupational Safety and Health, Universiti Putra Malaysia (UPM)
  4. Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM)

On-going

Assessment of obstetrics and gynecology prescribing patterns at women and children hospital Kuala Lumpur using WHO prescribing indicators

UCSI Research Excellence & Innovation Grant (REIG)

REIG-FPS-2020/050

  1. Pharmacy Department Tunku Azizah Women and Children Hospital Kuala Lumpur (Hospital Wanita Dan Kanak-Kanak Kuala Lumpur)

On-going

 

Formulation and Clinical Evaluation of Mangosteen And Seaweed- Impregnated Bio-Cellulose Facial Mask for Anti-Aging and Anti-Acne Effects

 

Pioneer Scientist Incentive Fund (PSIF)

Proj-In-FPS-024

 On-going
Evaluation of the utilization and provision of written medicine information (WMI) among consumers, community pharmacists and private general practitioners in Klang Valley, Malaysia

Pioneer Scientist Incentive Fund (PSIF)

Proj-In-FPS-014

 Completed

 

Supervision:

PhD students (Current)

  • Hee Mei Qi
  • Kaveeta A/P Pergas
  • Hoang Nguyen Thao My

Master students (Current)

  • Joan Nyanhongo

Master students (Completed)

  • Khadija Mallouk (2019)
  • Chang Lina (2018)
  • Mooi Xin Yi (2018)
  • Alice Ew Shu Min (2018)
  • Nithya A/P Palani (2018)
  • Anabelle Rose Joykin (2018)
  • Hari Pretha Nair A/P Raghvan (2018)

Undergraduate students (Current)

  • Ho Yi Kee
  • Keng Jing Wen

Publications

Book Chapter

  • Fatokun, O. (2018). Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry into the Pharmaceutical Markets. In Social and Administrative Aspects of Pharmacy in Low-and Middle-Income Countries: Present Challenges and Future Solutions (pp. 211–225). Elsevier Inc. https://doi.org/10.1016/B978-0-12-811228-1.00013-3

 

Journal Articles

  • Raghvan, H. P. N., & Fatokun, O. (2021). Factors associated with the intention of community pharmacists to report adverse drug reactions to regulatory authority in Malaysia: application of the theory of planned behaviour. International Journal of Pharmacy Practice.
  • Fatokun, O., Mooi, X. Y., Helweh, O., & Rajagopal, M. (2020). Barriers and facilitators to provision of written consumer medicines information among community pharmacists in Malaysia: a cross-sectional study. Journal of Pharmaceutical Health Services Research, 11(4), 419-422.
  • Fatokun, O. (2020). Risk Minimization Measures in Off-Label Drug Use: A Survey of Community Pharmacists in Malaysia. Current Drug Safety, 15(3), 181-189.
  • Fatokun, O. (2020). Fostering local production of essential medicines in Nigeria. Bulletin of the World Health Organization, 98(7), 507.
  • Fatokun, O. (2017). Cancer control reform in Nigeria. The Lancet Oncology. Lancet Publishing Group. https://doi.org/10.1016/S1470-2045(16)30650-7
  • Fatokun, O. (2016). Curbing the circulation of counterfeit medicines in Nigeria. The Lancet. Lancet Publishing Group. https://doi.org/10.1016/S0140-6736(16)32121-3
  • Fatokun, O. Olawepo, MN. (2016) Factors associated with prescribing restriction on oncology formulary drugs in Malaysia. International Journal of Clinical Pharmacy, 38 (5), 1075-1079. https://doi.org/10.1007/s11096-016-0372-8
  • Fatokun, O. (2014). Exploring antibiotic use and practices in a Malaysian community. International Journal of Clinical Pharmacy36(3), 564–569. https://doi.org/10.1007/s11096-014-9937-6
  • Khan, M. U., Shah, S., Ahmad, A., & Fatokun, O. (2014). Knowledge and attitude of healthcare workers about middle east respiratory syndrome in multispecialty hospitals of Qassim, Saudi Arabia. BMC Public Health14(1). https://doi.org/10.1186/1471-2458-14-1281
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2013). Factors determining the post-patent entry of generic medicines in Malaysia: A survey of the Malaysian generic pharmaceutical industry. Journal of Generic Medicines10(1), 22–33. https://doi.org/10.1177/1741134313483749
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2013). Generic industry’s perceptions of generic medicines policies and practices in Malaysia. Journal of Pharmacy Research7(1), 80–84. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L369167578
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. A. (2013). Time to entry of generic medicines in Malaysia: Implications for pharmaceutical cost containment. Journal of Pharmaceutical Health Services Research4(4), 203–210. https://doi.org/10.1111/jphs.12031
  • Fatokun, O., Ibrahim, M. I. M., & Hassali, M. A. (2011). Generic competition and drug prices in the Malaysian off-patent pharmaceutical market. Journal of Applied Pharmaceutical Science1(9), 33–37.

Journal Reviewers

  1. PlosOne
  2. BMC Health Services Research
  3. Value in Health Regional Issues
  4. Bulletin of the World Health Organization
  5. Journal of Pharmaceutical Health Services Research